Good Manufacturing Practice (GMP) is a system of quality assurance governing the manufacture of medicinal products and active pharmaceutical ingredients, as defined by regulatory frameworks such as those from the International Council for Harmonisation (e.g., Q7), U.S. Food and Drug Administration (21 CFR Parts 210/211), and European Medicines Agency (EU GMP). These guidelines require controlled manufacturing processes, qualified personnel, validated systems, comprehensive documentation, and quality oversight to ensure consistent product quality and suitability for clinical use.
Materials described as “GMP-compliant” are manufactured within such quality systems, incorporating defined procedures, environmental controls, and batch-level traceability. Regulatory authorities evaluate GMP compliance at the level of the manufacturing process rather than assigning a universal regulatory status to individual reagents. The acceptability of any material is therefore determined within the context of the overall process and regulatory submission.
GMP-compliant materials are required for the manufacture of investigational and approved medicinal products and are used in regulated environments, including clinical manufacturing and late-stage process development. Early-stage research may use research-use-only (RUO) materials, which are not subject to GMP requirements.
Applications
- Cell and gene therapy manufacturing (e.g., viral vectors, cell processing).
- Biopharmaceutical production (e.g., monoclonal antibodies, recombinant proteins, vaccines).
- Clinical development (e.g., investigational medicinal products for IND/CTA submissions).
- Regenerative medicine (e.g., stem cell–based products).
Key Attributes
- Regulatory alignment with GMP guidelines (ICH, FDA, EMA).
- Full traceability and batch documentation (e.g., CoA).
- Controlled and consistent manufacturing processes.
- Defined quality control testing based on intended use.
- Suitability for further validation and scale-up in clinical manufacturing contexts.
